Cargando…

Single Parameter Estimation Approach for Robust Estimation of SIR Model With Limited and Noisy Data: The Case for COVID-19

OBJECTIVE: The susceptible-infected-removed (SIR) model and its variants are widely used to predict the progress of coronavirus disease 2019 (COVID-19) worldwide, despite their rather simplistic nature. Nevertheless, robust estimation of the SIR model presents a significant challenge, particularly w...

Descripción completa

Detalles Bibliográficos
Autores principales: Senel, Kerem, Ozdinc, Mesut, Ozturkcan, Selcen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431866/
https://www.ncbi.nlm.nih.gov/pubmed/32580814
http://dx.doi.org/10.1017/dmp.2020.220
Descripción
Sumario:OBJECTIVE: The susceptible-infected-removed (SIR) model and its variants are widely used to predict the progress of coronavirus disease 2019 (COVID-19) worldwide, despite their rather simplistic nature. Nevertheless, robust estimation of the SIR model presents a significant challenge, particularly with limited and possibly noisy data in the initial phase of the pandemic. METHODS: The K-means algorithm is used to perform a cluster analysis of the top 10 countries with the highest number of COVID-19 cases, to observe if there are any significant differences among countries in terms of robustness. RESULTS: As a result of model variation tests, the robustness of parameter estimates is found to be particularly problematic in developing countries. The incompatibility of parameter estimates with the observed characteristics of COVID-19 is another potential problem. Hence, a series of research questions are visited. CONCLUSIONS: We propose a Single Parameter Estimation (SPE) approach to circumvent these potential problems if the basic SIR is the model of choice, and we check the robustness of this new approach by model variation and structured permutation tests. Dissemination of quality predictions is critical for policy- and decision-makers in shedding light on the next phases of the pandemic.